儿科维尼克脑病:一个系统的审查
Erik Oudman1,2, Jan W Wijnia1,2, Janice R Bidesie1,2
1Experimental Psychology, Helmholtz Institute, Utrecht University, 3584 CS Utrecht, The Netherlands.
Pediatric reports
|February 25, 2025
概括
儿科维尼克脑病变 (WE) 可以在没有酒精的情况下发生. 早期的恶心和吐预测了WE,而亲肠道营养中的胺对恢复至关重要,特别是在最佳剂量的情况下.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 营养科学 营养科学
背景情况:
- 沃尼克脑病 (Wernicke Encephalopathy,简称WE) 是一种神经疾病,通常与饮酒有关.
- 儿科WE可以由各种非酒精原因引起,包括营养不良和严重疾病.
研究的目的:
- 系统地审查儿科维尼克脑病症病例.
- 识别儿科WE的各种病因和临床表现.
- 评估儿科WE的诊断和治疗结果.
主要方法:
- 在30年内对88例儿科WE病例进行了系统审查.
- 分析病因,包括癌症,胃肠道疾病,营养不良和COVID-19.
- 对临床症状,诊断结果 (MRI) 和治疗方案的审查.
主要成果:
- 恶心 (60%) 和吐 (55%) 是常见的前兆症状.
- 37%的患者在诊断前接受了没有胺的肠胃营养,有风险发展为韦尼克-科萨科夫综合征 (WKS).
- 经典的WKS三位一体 (眼动障碍,精神状态变化,心动不良) 在大多数情况下都存在;MRI灵敏度85%. 较高的胺剂量改善了结果.
结论:
- 早期识别恶心和吐是预测儿科WE的关键.
- 管营养中提氨酸补充剂对于预防和治疗儿科WE至关重要.
- 最佳的胺剂量对于患者的康复和改善结果至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


